Healthtech
Solutions, Inc.
(HLTT),
Parent
Company of
Varian
Biopharmaceuticals Inc,
Medi-Scan
Inc. and
RevHeart Inc.,
Announces
the
Appointment of Edward Swanson, MD as New
Chief Executive Officer
New York, NY -- May 14, 2021 -- InvestorsHub NewsWire
-- Healthtech
Solutions, Inc. (OTC:
HLTT) ("Healthtech" or
the
"Company"), announced today
that Edward
(Ned) Swanson, M.D., was named Chief Executive
Officer.
Dr. Swanson has a
unique background and skillset that is particularly well suited to
lead Healthtech, combining scientific, clinical, and industry
knowledge. He is a co-founder of PolarityTE, Inc,
(Nasdaq: PTE), a biotech company developing a range of regenerative
tissue products and biomaterials, led by its flagship product
SkinTE®.
As a co-founder of PolarityTE, Dr. Swanson has gained extensive
experience building and operating a public company, serving
numerous roles as a former Director, Chief Operating Officer, and
Chief Medical Officer. Additionally, he served as CEO of
subsidiaries of PolarityTE that offer preclinical contract research
services,
Utah CRO Services, Inc. and IBEX Preclinical Research,
Inc. These
roles have provided Dr. Swanson
with deep
industry knowledge and know-how related to company
formation, financing, product development, medical
and regulatory affairs, manufacturing, business development, and
commercialization within healthcare.
Prior to
PolarityTE, Dr. Swanson was a resident in plastic and reconstructive
surgery
at
The Johns Hopkins
University School of Medicine. He has published more than 45 peer-reviewed
papers, authored four
book chapters,
and delivered 30 conference presentations.
Dr. Swanson
completed his
undergraduate training in bioengineering at the University of
Pennsylvania,
School
of Engineering and
Applied Science, and obtained his
M.D.
from Harvard
Medical
School.
"With Ned Swanson
at the helm of Healthtech Solutions, we have the leadership and
expertise of an individual who has demonstrated success at both
medical bioengineering and effective public company
stewardship at C-level," said Healthtech Solutions
Chairman David Rubin. "His direction will facilitate a rise
to a new level for the company and serve to deliver continued
growth and
shareholder value."
"I am thrilled to
be joining the Healthtech team to build out a unique
portfolio-style business model to bring innovative biotech and
medical device technologies to the market and impact patient lives.
The decentralized development of assets in this structure leverages
nimble operating efficiencies at the subsidiary level combined with
the experience and skillsets of the management team of
Healthtech," Dr. Swanson
said. "Our goal is to
identify, develop and accelerate the growth of promising
technologies while fostering an innovative
ecosystem amongst our subsidiaries that results in synergies at all
levels. We believe our model aligns both entrepreneurs and
shareholders and will result in value, driven at all levels, most
importantly to patients and the healthcare system."
NO OFFER OR
SOLICITATION
This communication
shall neither constitute an offer to sell nor the solicitation of an offer
to buy any securities, nor shall there be any sale of securities in
any jurisdiction in which the offer, solicitation or sale would be
unlawful prior to the registration or qualification under the
securities laws of any such jurisdiction.
FORWARD-LOOKING
STATEMENTS
Any statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Forward-looking
statements, which involve assumptions and describe the Company's
future plans, strategies and expectations, are generally
identifiable by use of the words "may," "should," "would," "will,"
"could," "scheduled," "expect," "anticipate," "estimate,"
"believe," "intend," "seek" or "project" or the negative of these
words or other variations on these words or comparable terminology.
Such forward-looking statements are not meant to predict or
guarantee actual results, performance, events or circumstances, and
may not be realized because they are based upon the Company's
current projections, plans, objectives, beliefs, expectations,
estimates, and assumptions, and are subject to several risks and
uncertainties and other influences, over many of which the Company
has no control. Actual results and the timing of certain events and
circumstances may differ materially from those described by the
forward-looking statements as a result of these risks and
uncertainties. These and other factors are identified and described
in more detail in the Company's filings with the SEC. The Company
does not undertake to update these forward-looking
statements.
Contacts:
Investors and
Media
Chairman@HLTT.tech
President@HLTT.tech
CEO@HLTT.tech